This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Olshwang, D. Articles by Magora, F. Search for Related Content PubMed PubMed Citation Articles by Olshwang, D. Articles by Magora, F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB GUANETHIDINE Medline Plus Health Information Vascular Diseases Social Bookmarking                         What's this?

Intravenous Regional Guanethidine Treatment in Peripheral Vascular Disease

G. Beer

F. Magora

Twenty-eight patients with spastic and obstructive vascular disease were treated with intravenous regional guanethidine (IRG). The drug was injected into the affected hand or foot in doses of 10 or 20 mg, respectively. Temper ature and strain-gauge plethysmography curves of the extremity were recorded before treatment, and three to four times during the subsequent 10 days. The effects of IRG, as observed by clinical laboratory examinations, were good in 8 of 12 patients. But in patients suffering from Bürger's disease or from major vessel obstructive disease, the results were not as good. However, in most pa tients IRG proved beneficial in relieving pain, an effect which sometimes out lasted objective improvements. IRG treatment is a simple and safe method for prolonged chemical sympathectomy.

Angiology, Vol. 31, No. 9, 639-645 (1980)
DOI: 10.1177/000331978003100905


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. I. Paraskevas, C. D. Liapis, D. D. Briana, and D. P. Mikhailidis Thromboangiitis Obliterans (Buerger's Disease): Searching for a Therapeutic Strategy Angiology, February 1, 2007; 58(1): 75 - 84. [Abstract] [PDF]

				K. I. Paraskevas, A. A. Trigka, and M. Samara Successful Intravenous Regional Sympathetic Blockade (Bier's Block) with Guanethidine and Lidocaine in a Patient with Advanced Buerger's Disease (Thromboangiitis Obliterans): A Case Report Angiology, July 1, 2005; 56(4): 493 - 496. [Abstract] [PDF]

				A. Stumpflen, A. Ahmadi, M. Atteneder, M. Gschwandtner, S. Hofmann, T. Maca, G. Schnurer, E. Minar, and A. Stumpflen Effects of Transvenous Regional Guanethidine Block in the Treatment of Critical Finger Ischemia Angiology, February 1, 2000; 51(2): 115 - 122. [Abstract] [PDF]

				C.A. Caputi, G. De Carolis, and C. Tomasetti Regional Intravenous Ketanserin and Guanethidine Therapy in Raynaud's Phenomenon Angiology, June 1, 1991; 42(6): 473 - 480. [Abstract] [PDF]